Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2008 063 676.3 |
| 96 | EP file number | EAKZ | 15 17 3766.5 |
| 97 | EP publication number | EPN | 2952177 |
| 54 | Designation/title | TI | ZUSAMMENSETZUNG MIT SPHINGOSIN-1-PHOSPHAT (S1P)-REZEPTORMODULATOREN |
| 51 | IPC main class | ICM
(ICMV) | A61K 9/20 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 9/00 (2006.01), A61K 9/70 (2006.01), A61K 31/133 (2006.01), A61K 31/137 (2006.01) |
| 22 | DE application date | DAT | Oct 9, 2008 |
| 96 | EP application date | EAT | Oct 9, 2008 |
| 43 | Date of first publication | OT | Dec 9, 2015 |
| Date of publication of grant | PET | Jan 20, 2021 |
| 71/73 | Applicant/owner | INH | Novartis AG, Basel, CH |
| 72 | Inventor | IN | RUEGGER, Colleen, 4056 Basel, CH; AMBUEHL, Michael, 4056 Basel, CH |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
979482 P
Oct 12, 2007
|
| Due date | FT
FG | Oct 31, 2025
Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002952177
Searchable text:
EP000002952177
Original document:
EP000002952177B1
Searchable text:
EP000002952177B1 |
| 43 | Date of first publication | EVT | Dec 9, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Dec 10, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 1, 2024
(Show all update days)(Hide all update days)- Oct 1, 2024
- Sep 19, 2024
- St.36: changed (technical change)
- Dec 10, 2015
- Date of the first transfer into DPMAregister
|
